News

The license authorized making and selling cellular and animal models in a restricted field, for research uses only expressly excluding the use of such product for any commercial

The new prescription acne treatment received approval from the FDA in December, 2008 and will be on pharmacy shelves in the US in the first quarter of 2009.

Neosalus, formulated with Quinnova’s patented Proderm Technology, provides skin barrier repair, protection, and moisturization. Christopher Hensby, senior vice president of Quinnova, said: “To treat recalcitrant skin conditions such

Mr Vargas joined Depomed as vice president of business development in December 2002, while Ms Cameron joined Depomed as controller in July 2007 and was named interim principal

The investigational new drug applications (INDs) signify the company’s intentions to begin clinical investigation for CB-182,804, a Cubist-discovered, potent, cidal, IV lipopeptide in development as therapy for the

“Our second quarter results demonstrate the strength of our business model with its strong recurring revenue and cash flow,” stated Gioacchino De Chirico, president and chief executive officer.

Through its subsidiary UPS Supply Chain Solutions, United Parcel Service (UPS) said that it has assumed control of two key Merck distribution centers, which provide Merck with temperature-sensitive

In this role, Mr Mengler will be responsible for expanding the company’s generic business by growing capability in the US market while driving global opportunities. Mr Mengler comes

Mr Byle is presently vice-president of technology for Dockwise, a public, international company, where he is in charge of its R&D program and intellectual property portfolio. Michael Cohen,